Ligand Pharmaceuticals Incorporated (LGND)

Exchange
NASDAQ
Symbol
LGND
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs globally. The company is headquartered in San Diego, California.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    112.06
  • High
    115.47
  • Low
    111.00
  • Close
    114.64
  • Volume
    551,595

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
4.05
Receivables turnover
4.32
Payables turnover
40.03
Working capital turnover
0.77
Days of inventory on hand (DOH)
90.05
Days of sales outstanding (DSO)
84.40
Number of days of payables
9.12
Fixed asset turnover
10.89
Total asset turnover
0.22
 Liquidity ratios
Current ratio
14.15
Quick ratio
12.49
Cash ratio
10.15
Cash conversion cycle
165.33
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.12
Interest coverage
95.50
 Profitability ratios
Gross profit margin
21.25%
Operating profit margin
7.02%
Pretax margin
36.47%
Net profit margin
30.68%
Operating return on assets (Operating ROA)
1.52%
Return on assets (ROA)
6.63%
Return on total capital
8.94%
Return on equity (ROE)
7.44%